DRUG SUSCEPTIBILITY USING RARE CELL DETECTION SYSTEM
    3.
    发明申请
    DRUG SUSCEPTIBILITY USING RARE CELL DETECTION SYSTEM 审中-公开
    使用稀有细胞检测系统的药物不耐症

    公开(公告)号:US20130084579A1

    公开(公告)日:2013-04-04

    申请号:US13622740

    申请日:2012-09-19

    CPC classification number: G01N33/94 B01L3/50215 G01N33/5011 G01N33/582

    Abstract: Methods for determining the efficacy of a given drug for a specific patient with cancer in vitro prior to, or after, the initiation of treatment of the patient are disclosed. Blood from the cancer patient is separated into an assay test tube and a control test tube. The blood in the assay test tube is exposed to a cancer drug. The two test tubes are then visually examined and compared to determine the effect of the cancer drug on cancer cells, other rare cells in the blood, or on normal constituents of the blood of a cancer patient.

    Abstract translation: 公开了在开始治疗患者之前或之后确定给定药物对特定癌症患者的功效的方法。 将来自癌症患者的血液分离成测定试管和对照试管。 测定试管中的血液暴露于癌症药物。 然后目视检查并比较两个试管,以确定癌症药物对癌细胞,血液中的其它罕见细胞或癌症患者血液正常成分的影响。

Patent Agency Ranking